QQ客服 官方微博 反馈留言

	Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non-small-cell lung cancer: A network meta-analysis of nine eligible randomized controlled trials involving 5,059 patients
	Miao, Ying-Ying; Liu, Gui-Feng; Zhang, Shu-Hua; Li, Xue-Feng; Yu, Shao-Nan
刊名	JOURNAL OF CELLULAR PHYSIOLOGY
	2019
卷号	234期号:4
关键词	advanced or metastatic non-small-cell lung cancer (NSCLC) adverse events Bayesian network model efficacy randomized controlled trials targeted agents
ISSN号	0021-9541
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3511326
专题	吉林大学白求恩第三医院
推荐引用方式 GB/T 7714	Miao, Ying-Ying,Liu, Gui-Feng,Zhang, Shu-Hua,et al. Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non-small-cell lung cancer: A network meta-analysis of nine eligible randomized controlled trials involving 5,059 patients[J]. JOURNAL OF CELLULAR PHYSIOLOGY,2019,234(4).
APA	Miao, Ying-Ying,Liu, Gui-Feng,Zhang, Shu-Hua,Li, Xue-Feng,&Yu, Shao-Nan.(2019).Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non-small-cell lung cancer: A network meta-analysis of nine eligible randomized controlled trials involving 5,059 patients.JOURNAL OF CELLULAR PHYSIOLOGY,234(4).
MLA	Miao, Ying-Ying,et al."Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non-small-cell lung cancer: A network meta-analysis of nine eligible randomized controlled trials involving 5,059 patients".JOURNAL OF CELLULAR PHYSIOLOGY 234.4(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。